Transcat, Inc. - Common Stock (TRNS)
Healthcare › Instruments For Meas & Testing of Electricity & Elec Signals
Price History
Feb 9, 2026 — Jul 7, 2026Investment Snapshot
- Trading 333% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 4/9 — moderate financial health
- ROE of 1.9% — below-average profitability
- Revenue growing at 19% annually
Transcat, Inc. - Common Stock (TRNS) is a Healthcare company operating in Instruments For Meas & Testing of Electricity & Elec Signals, listed on the NASDAQ , with a market capitalisation of $857 million . Key value metrics: P/E ratio 148.1, P/B ratio 2.85, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Transcat, Inc. - Common Stock — Fundamental Analysis Summary
Transcat, Inc. - Common Stock (TRNS) is currently trading 333% above its Graham Number of $21.18, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 148.1x.
On financial health, TRNS shows a moderate Piotroski F-Score of 4/9, and modest return on equity of 1.9% (sector average: -20.6%), and manageable leverage with a debt-to-equity ratio of 0.33.
StockPik's composite Value Score for TRNS is 54/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
TRNS reports a moderate gross margin of 30.0% (sector average: 39.4%) and a modest operating margin of 3.4%.
TRNS shows revenue growing at 19% year-over-year, with earnings declining at 63%.